Flagship explainer
What drives Kestra Medical Technologies, Ltd.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$132M | FY2026 |
| |
| Income before tax | −$131M | FY2026 |
|
| Operating income | −$135M | FY2026 |
|
| $95.1M | FY2026 |
| |
| Ending assets | $358M | FY2026 |
|
| Beginning assets | $296M | FY2025 |
|
| $260M | FY2026 |
| |
| $205M | FY2025 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-303397